• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病:从遗传学到分子功能障碍及靶向治疗方法

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches.

作者信息

Huang Yue, Wei Jun, Cooper Antony, Morris Margaret J

机构信息

China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.

出版信息

Genes Dis. 2022 Feb 5;10(3):786-798. doi: 10.1016/j.gendis.2021.12.015. eCollection 2023 May.

DOI:10.1016/j.gendis.2021.12.015
PMID:37396535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10308076/
Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder in the elderly. As the pathogenesis of PD is still not fully understood, medications with the capacity of halting the disease progression are currently unavailable. The discovery of genes that are causative for, or increase susceptibility to PD is pivotal for the development of novel therapeutic approaches, as they are critical for the onset of PD and the molecular pathways underlying its pathogenesis. By reviewing relevant data, we discuss causative genes, and those associated with PD susceptibility and quantitative traits. Through Gene Ontology database and STRING analysis, we emphasize the roles of inorganic cation transmembrane transport pathways and hypothalamic pituitary thyroid axis, in addition to the established roles of inflammation/oxidative stress and mitochondrial dysfunction in the pathogenesis of PD. It is hoped these insights 1) untangle the clinical complex presentations of PD, 2) reveal the interwoven molecular network leading to PD, and 3) identify critical molecular targets to facilitate novel PD drug discovery, with a view to providing improved consultation and personalized medicine for patients with PD in the future.

摘要

帕金森病(PD)是老年人中最常见的神经退行性运动障碍。由于PD的发病机制仍未完全明确,目前尚无能够阻止疾病进展的药物。发现导致PD或增加其易感性的基因对于开发新的治疗方法至关重要,因为它们对PD的发病以及其发病机制背后的分子途径至关重要。通过回顾相关数据,我们讨论了致病基因以及与PD易感性和数量性状相关的基因。通过基因本体数据库和STRING分析,我们强调了无机阳离子跨膜运输途径和下丘脑 - 垂体 - 甲状腺轴的作用,此外还强调了炎症/氧化应激和线粒体功能障碍在PD发病机制中已确立的作用。希望这些见解能够:1)理清PD复杂的临床症状;2)揭示导致PD的相互交织的分子网络;3)识别关键分子靶点以促进新型PD药物的发现,以期在未来为PD患者提供更好的咨询和个性化医疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10308076/18d71386e988/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10308076/2f452749ed5b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10308076/18d71386e988/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10308076/2f452749ed5b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08b/10308076/18d71386e988/gr2.jpg

相似文献

1
Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches.帕金森病:从遗传学到分子功能障碍及靶向治疗方法
Genes Dis. 2022 Feb 5;10(3):786-798. doi: 10.1016/j.gendis.2021.12.015. eCollection 2023 May.
2
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
3
Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.构建帕金森病标志物加权蛋白质-蛋白质相互作用网络,对共表达基因进行优先级排序。
Gene. 2019 May 20;697:67-77. doi: 10.1016/j.gene.2019.02.026. Epub 2019 Feb 16.
4
Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.帕金森病中的线粒体功能障碍:新的发病机制及治疗展望。
Curr Neurol Neurosci Rep. 2018 Apr 3;18(5):21. doi: 10.1007/s11910-018-0829-3.
5
Current insights into pathogenesis of Parkinson's disease: Approach to mevalonate pathway and protective role of statins.目前对帕金森病发病机制的认识:甲羟戊酸途径的研究进展和他汀类药物的保护作用。
Biomed Pharmacother. 2017 Jun;90:724-730. doi: 10.1016/j.biopha.2017.04.038. Epub 2017 Apr 15.
6
A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.一项关于将帕金森病中线粒体功能障碍与神经炎症联系起来的分子方法的系统综述。
Neurol Sci. 2021 Nov;42(11):4459-4469. doi: 10.1007/s10072-021-05551-1. Epub 2021 Sep 3.
7
Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.线粒体功能障碍与帕金森病:发病机制与治疗策略。
Neurochem Res. 2023 Aug;48(8):2285-2308. doi: 10.1007/s11064-023-03904-0. Epub 2023 Mar 21.
8
Repositioning drugs by targeting network modules: a Parkinson's disease case study.通过靶向网络模块对药物进行再定位:帕金森病案例研究。
BMC Bioinformatics. 2017 Dec 28;18(Suppl 14):532. doi: 10.1186/s12859-017-1889-0.
9
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
10
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.α-突触核蛋白导致帕金森病中线粒体功能障碍的共同机制。
J Mol Biol. 2023 Jun 15;435(12):167992. doi: 10.1016/j.jmb.2023.167992. Epub 2023 Feb 2.

引用本文的文献

1
Gut dysbiosis as a potential driver of Parkinson's and Alzheimer's disease pathogenesis.肠道微生物群失调作为帕金森病和阿尔茨海默病发病机制的潜在驱动因素。
Front Neurosci. 2025 Aug 13;19:1600148. doi: 10.3389/fnins.2025.1600148. eCollection 2025.
2
Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions.神经退行性疾病中靶向小胶质细胞的生物标志物与治疗策略:现状与未来方向
Mol Neurodegener. 2025 Jul 10;20(1):82. doi: 10.1186/s13024-025-00867-4.
3
The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.

本文引用的文献

1
Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease.单细胞转录组和TCR分析揭示帕金森病中活化和扩增的T细胞群体。
Cell Discov. 2021 Jul 20;7(1):52. doi: 10.1038/s41421-021-00280-3.
2
Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.帕金森病的非运动症状:早期精神和认知功能障碍的神经生物学。
Neuroscientist. 2023 Feb;29(1):97-116. doi: 10.1177/10738584211011979. Epub 2021 May 8.
3
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.
镁在帕金森病中的作用:现状及对未来研究的启示。
Int J Mol Sci. 2024 Aug 1;25(15):8425. doi: 10.3390/ijms25158425.
4
Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment.探索与神经认知障碍相关的脑部疾病的基因共表达网络及药物重新利用机会。
Brain Sci. 2023 Nov 7;13(11):1564. doi: 10.3390/brainsci13111564.
5
Inhibition of ACSL4 Alleviates Parkinsonism Phenotypes by Reduction of Lipid Reactive Oxygen Species.ACSL4 抑制通过减少脂质活性氧缓解帕金森病表型。
Neurotherapeutics. 2023 Jul;20(4):1154-1166. doi: 10.1007/s13311-023-01382-4. Epub 2023 May 3.
全基因组生存研究鉴定出帕金森病认知进展的新型突触位点和多基因评分。
Nat Genet. 2021 Jun;53(6):787-793. doi: 10.1038/s41588-021-00847-6. Epub 2021 May 6.
4
Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.帕金森病认知和运动进展的全基因组关联研究。
Mov Disord. 2021 Feb;36(2):424-433. doi: 10.1002/mds.28342. Epub 2020 Oct 28.
5
Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis.LRRK2 突变型 hiPSC 衍生的多巴胺能神经元中 mRNA 翻译缺陷导致钙稳态失调。
Cell Stem Cell. 2020 Oct 1;27(4):633-645.e7. doi: 10.1016/j.stem.2020.08.002. Epub 2020 Aug 25.
6
Current and projected future economic burden of Parkinson's disease in the U.S.美国帕金森病当前及预计未来的经济负担
NPJ Parkinsons Dis. 2020 Jul 9;6:15. doi: 10.1038/s41531-020-0117-1. eCollection 2020.
7
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?富含亮氨酸重复激酶2与α-突触核蛋白:帕金森病中各自独立还是协同发挥作用的因素?
Front Neurosci. 2020 Jun 17;14:577. doi: 10.3389/fnins.2020.00577. eCollection 2020.
8
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.大规模通路特异性多基因风险和转录组群落网络分析鉴定帕金森病中的新功能通路。
Acta Neuropathol. 2020 Sep;140(3):341-358. doi: 10.1007/s00401-020-02181-3. Epub 2020 Jun 29.
9
Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors.揭示甲状腺激素紊乱与帕金森病病理之间的关系:机制与风险因素。
J Endocrinol Invest. 2021 Jan;44(1):1-13. doi: 10.1007/s40618-020-01314-5. Epub 2020 Jun 4.
10
Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study.亚洲人群帕金森病风险基因座的鉴定及亚洲人与欧洲人风险比较的全基因组关联研究。
JAMA Neurol. 2020 Jun 1;77(6):746-754. doi: 10.1001/jamaneurol.2020.0428.